GE HealthCare Innovates in Cardiac Arrhythmia Management

In the ongoing battle against cardiovascular disease, GE HealthCare its latest innovation in electrophysiology (EP), the Prucka 3, accompanied by the complementary CardioLab EP Recording system. This technology aims to revolutionize the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation (AFib), a prevalent and potentially life-threatening condition affecting millions worldwide.

AFib stands as the most prevalent cardiac arrhythmia globally, impacting approximately 40 million individuals worldwide, as reported by PMFarma. According to projections, AFib's prevalence is expected to rise significantly in the coming decades. 

In Mexico alone, over half a million people are affected by this condition, highlighting the urgent need for advanced diagnostic and treatment solutions. GE HealthCare's Prucka 3 system is poised to address this challenge, leveraging over two decades of expertise in electrophysiology to provide clinicians with accurate and efficient tools for managing cardiac arrhythmias. 

Key features of the Prucka 3 with CardioLab EP Recording system include enhanced signal filtering capabilities, dual real-time display options, cycle length labeling on signals, multiple review windows, and ClearMatch functionality for morphology matching.

The Prucka 3 system digital platform is designed to ensure high signal fidelity while minimizing environmental noise through advanced signal-filtering capabilities. This innovative technology not only enhances signal clarity but also lays the groundwork for future advancements in electrophysiology, offering clinicians a pathway to emerging technologies for improved patient care.

The Prucka 3 represents a significant advancement for EP labs, given its capacity to deliver outstanding signals and elevate the overall EP lab experience through its digital architecture, according to Devon Bream, General Manager of Invasive Cardiology, GE HealthCare.

The Prucka 3 system is part of GE HealthCare's comprehensive cardiology care portfolio, which addresses various challenges faced in cardiology today. Recent enhancements to the portfolio include the Allia IGS Pulse, a next-generation image-guided system, and CardioVisio for Atrial Fibrillation, which offers valuable insights for healthcare providers.

GE Healthcare in Mexico

GE Healthcare has a large footprint in Mexico, with more than 3,000 employees, a factory in both Ciudad Juarez and Monterrey, and an office in Mexico City.  The company produces magnetic resonance imaging (MRIs), ECG scanners, mammography equipment, interventional equipment for minimally invasive surgery and more, Guillermo Murra, Executive Director and General Manager told MBN.